A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors

被引:49
作者
Cockrell, Adam S.
Ma, Hong
Fu, Kailing
McCown, Thomas J.
Kafri, Tal
机构
[1] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
关键词
lentivirus; vector; packaging cell; trans-lentiviral; conditional SIN vector; inducible gene expression; tetracycline; gene therapy;
D O I
10.1016/j.ymthe.2005.12.015
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lentiviral vector safety has been the impetus underlying the progress in packaging cell line development. The prospects of generating replication-competent lentiviruses (RCLs) and the potential for vector mobilization continue to be the driving force for the advancement of packaging cell lines. We have exploited the trans-lentiviral packaging system to develop the SODk3 packaging cell line for the generation of conditional self-inactivating (cSIN) vectors. Separating the gag-pol genome into two distinct expression cassettes (gag-pro and vpr-RT-IN) may reduce the potential for RCL formation, while concurrently employing cSIN vectors supports retention of the SIN phenotype in target cells and alleviates technical constraints associated with generating producer cell lines. Through development of the SODk3 packaging cell line we determined that the ratio of Gag/Pol in vector particles may be used as an indicator for packaging cell clones that yield high vector titers. Conditional SIN vector titers (1 X 10(7) TU/ml) were augmented through clonal selection. Distinct producer cell clones revealed a parallel between vector titer and transgene expression levels. We exploited this observation to demonstrate that incorporation of an internal ribosome entry site between the GFP marker and a relevant transgene affords efficient selection of high-titer producer cell lines. Furthermore, cSIN vectors generated from SODk3 packaging cells imparted efficient transduction of primary human fibroblasts, an indication of the future applicability of the SODk3 packaging cell line.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 27 条
[1]   Tet B or not tet B: Advances in tetracycline-inducible gene expression - Commentary [J].
Blau, HM ;
Rossi, FMV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :797-799
[2]   Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells [J].
Bukovsky, AA ;
Song, JP ;
Naldini, L .
JOURNAL OF VIROLOGY, 1999, 73 (08) :7087-7092
[3]   The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles [J].
Chen, SW ;
Chiu, HC ;
Liao, WH ;
Wang, FD ;
Chen, SSL ;
Wang, CT .
VIROLOGY, 2004, 318 (02) :534-541
[4]   A new-generation stable inducible packaging cell line for lentiviral vectors [J].
Farson, D ;
Witt, R ;
McGuinness, R ;
Dull, T ;
Kelly, M ;
Song, JP ;
Radeke, R ;
Bukovsky, A ;
Consiglio, A ;
Naldini, L .
HUMAN GENE THERAPY, 2001, 12 (08) :981-997
[5]   Continuous high-titer HIV-1 vector production [J].
Ikeda, Y ;
Takeuchi, Y ;
Martin, F ;
Cosset, FL ;
Mitrophanous, K ;
Collins, M .
NATURE BIOTECHNOLOGY, 2003, 21 (05) :569-572
[6]   SIGNALS FOR RIBOSOMAL FRAMESHIFTING IN THE ROUS-SARCOMA VIRUS GAG-POL REGION [J].
JACKS, T ;
MADHANI, HD ;
MASIARZ, FR ;
VARMUS, HE .
CELL, 1988, 55 (03) :447-458
[7]   A packaging cell line for lentivirus vectors [J].
Kafri, T ;
van Praag, H ;
Ouyang, L ;
Gage, FH ;
Verma, IM .
JOURNAL OF VIROLOGY, 1999, 73 (01) :576-584
[8]   Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences [J].
Kaul, M ;
Yu, H ;
Ron, Y ;
Dougherty, JP .
VIROLOGY, 1998, 249 (01) :167-174
[9]   A stable system for the high-titer production of multiply attenuated lentiviral vectors [J].
Klages, N ;
Zufferey, R ;
Trono, D .
MOLECULAR THERAPY, 2000, 2 (02) :170-176
[10]   AN ACTIVE-SITE MUTATION IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEINASE (PR) CAUSES REDUCED PR ACTIVITY AND LOSS OF PR-MEDIATED CYTOTOXICITY WITHOUT APPARENT EFFECT ON VIRUS MATURATION AND INFECTIVITY [J].
KONVALINKA, J ;
LITTERST, MA ;
WELKER, R ;
KOTTLER, H ;
RIPPMANN, F ;
HEUSER, AM ;
KRAUSSLICH, HG .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7180-7186